Lotus Historical Balance Sheet

LOTUSEYE

73.83 3.51 4.99%

Trend analysis of Lotus Eye Hospital balance sheet accounts such as Other Current Liab of 19.8 M provides information on Lotus Eye's total assets, liabilities, and equity, which is the actual value of Lotus Eye Hospital to its prevalent stockholders. By breaking down trends over time using Lotus Eye balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Lotus Eye Hospital latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lotus Eye Hospital is a good buy for the upcoming year.

Lotus Eye Inventory

27.47 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Eye Hospital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Lotus Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lotus Eye Hospital at a specified time, usually calculated after every quarter, six months, or one year. Lotus Eye Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lotus Eye and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lotus currently owns. An asset can also be divided into two categories, current and non-current.

Lotus Eye Balance Sheet Chart

At this time, Lotus Eye's Property Plant And Equipment Gross is fairly stable compared to the past year.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Lotus Eye assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Lotus Eye Hospital books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Lotus Eye's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lotus Eye Hospital current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Eye Hospital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

At this time, Lotus Eye's Property Plant And Equipment Gross is fairly stable compared to the past year.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	12.4M	6.7M	11.1M	5.9M
Total Assets	616.0M	631.9M	666.3M	647.5M

Short Long Term Debt Total Total Assets

Lotus Eye balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Accounts Payable	Net Receivables	Short Term Debt	Retained Earnings	Intangible Assets	Long Term Debt
Common Stock Shares Outstanding		-0.2	0.28	-0.88	-0.77	0.0	-0.44	-0.18	0.23	0.17	0.16	0.29	0.33	0.39	-0.95	0.11	-0.7	-0.35	-0.21	0.07	-0.34	-0.66	0.03	0.08	0.11	-0.35
Total Assets	-0.2		0.36	0.34	0.32	0.95	-0.02	-0.07	0.15	0.48	-0.26	0.45	0.17	0.16	0.42	-0.43	0.34	0.79	-0.64	-0.12	-0.09	0.07	0.79	0.83	-0.48	-0.35
Short Long Term Debt Total	0.28	0.36		-0.24	-0.31	0.46	-0.01	-0.17	0.36	0.03	0.15	0.49	0.77	0.01	-0.22	-0.29	-0.15	0.39	-0.24	0.03	-0.19	-0.07	0.29	0.55	-0.12	-0.3
Other Current Liab	-0.88	0.34	-0.24		0.85	0.1	0.42	0.26	-0.29	0.12	-0.24	-0.3	-0.21	-0.11	0.9	-0.36	0.8	0.3	0.06	-0.18	0.21	0.47	0.04	-0.02	-0.23	0.38
Total Current Liabilities	-0.77	0.32	-0.31	0.85		0.04	0.49	0.33	-0.38	0.13	-0.27	-0.18	-0.14	-0.11	0.75	-0.2	0.98	0.28	0.19	0.14	0.26	0.34	0.11	0.01	-0.2	0.14
Total Stockholder Equity	0.0	0.95	0.46	0.1	0.04		-0.09	-0.18	0.28	0.42	-0.17	0.54	0.16	0.21	0.22	-0.38	0.05	0.78	-0.66	-0.19	-0.14	0.0	0.78	0.92	-0.46	-0.41
Property Plant And Equipment Net	-0.44	-0.02	-0.01	0.42	0.49	-0.09		0.42	-0.42	0.05	0.03	-0.41	-0.14	0.3	0.4	0.03	0.49	-0.05	0.46	-0.37	0.73	0.3	-0.1	0.13	-0.43	0.45
Net Debt	-0.18	-0.07	-0.17	0.26	0.33	-0.18	0.42		-0.98	0.52	0.43	-0.74	-0.28	0.27	0.11	0.22	0.26	-0.44	-0.03	-0.19	0.51	0.43	0.03	-0.22	-0.23	0.28
Cash	0.23	0.15	0.36	-0.29	-0.38	0.28	-0.42	-0.98		-0.47	-0.38	0.8	0.41	-0.25	-0.15	-0.28	-0.29	0.49	-0.05	0.17	-0.53	-0.42	0.05	0.32	0.18	-0.32
Non Current Assets Total	0.17	0.48	0.03	0.12	0.13	0.42	0.05	0.52	-0.47		-0.12	-0.27	0.07	0.7	0.01	0.0	0.12	-0.15	-0.7	-0.41	0.18	-0.19	0.51	0.25	-0.43	-0.01
Non Currrent Assets Other	0.16	-0.26	0.15	-0.24	-0.27	-0.17	0.03	0.43	-0.38	-0.12		-0.33	-0.2	-0.16	-0.3	-0.07	-0.31	-0.2	0.07	0.03	0.24	0.59	0.02	-0.11	-0.03	0.25
Cash And Short Term Investments	0.29	0.45	0.49	-0.3	-0.18	0.54	-0.41	-0.74	0.8	-0.27	-0.33		0.47	-0.22	-0.21	-0.27	-0.08	0.69	-0.13	0.45	-0.6	-0.41	0.28	0.61	0.12	-0.73
Non Current Liabilities Total	0.33	0.17	0.77	-0.21	-0.14	0.16	-0.14	-0.28	0.41	0.07	-0.2	0.47		0.01	-0.29	-0.17	0.07	0.14	-0.2	0.26	-0.29	-0.43	0.17	0.19	0.08	-0.3
Inventory	0.39	0.16	0.01	-0.11	-0.11	0.21	0.3	0.27	-0.25	0.7	-0.16	-0.22	0.01		-0.21	0.05	-0.11	-0.3	-0.25	-0.66	0.24	-0.49	0.2	0.26	-0.48	0.24
Other Current Assets	-0.95	0.42	-0.22	0.9	0.75	0.22	0.4	0.11	-0.15	0.01	-0.3	-0.21	-0.29	-0.21		-0.25	0.68	0.46	0.0	-0.25	0.31	0.54	0.18	0.1	-0.31	0.33
Other Stockholder Equity	0.11	-0.43	-0.29	-0.36	-0.2	-0.38	0.03	0.22	-0.28	0.0	-0.07	-0.27	-0.17	0.05	-0.25		-0.23	-0.49	0.18	0.13	0.2	-0.12	-0.4	-0.35	0.46	-0.1
Total Liab	-0.7	0.34	-0.15	0.8	0.98	0.05	0.49	0.26	-0.29	0.12	-0.31	-0.08	0.07	-0.11	0.68	-0.23		0.3	0.18	0.21	0.21	0.25	0.12	0.05	-0.18	0.08
Total Current Assets	-0.35	0.79	0.39	0.3	0.28	0.78	-0.05	-0.44	0.49	-0.15	-0.2	0.69	0.14	-0.3	0.46	-0.49	0.3		-0.23	0.15	-0.23	0.22	0.54	0.76	-0.24	-0.39
Common Stock	-0.21	-0.64	-0.24	0.06	0.19	-0.66	0.46	-0.03	-0.05	-0.7	0.07	-0.13	-0.2	-0.25	0.0	0.18	0.18	-0.23		0.23	0.14	0.09	-0.72	-0.38	0.23	0.24
Current Deferred Revenue	0.07	-0.12	0.03	-0.18	0.14	-0.19	-0.37	-0.19	0.17	-0.41	0.03	0.45	0.26	-0.66	-0.25	0.13	0.21	0.15	0.23		-0.42	-0.02	-0.19	-0.15	0.63	-0.64
Accounts Payable	-0.34	-0.09	-0.19	0.21	0.26	-0.14	0.73	0.51	-0.53	0.18	0.24	-0.6	-0.29	0.24	0.31	0.2	0.21	-0.23	0.14	-0.42		0.4	0.12	-0.05	-0.41	0.53
Net Receivables	-0.66	0.07	-0.07	0.47	0.34	0.0	0.3	0.43	-0.42	-0.19	0.59	-0.41	-0.43	-0.49	0.54	-0.12	0.25	0.22	0.09	-0.02	0.4		0.08	-0.05	-0.13	0.32
Short Term Debt	0.03	0.79	0.29	0.04	0.11	0.78	-0.1	0.03	0.05	0.51	0.02	0.28	0.17	0.2	0.18	-0.4	0.12	0.54	-0.72	-0.19	0.12	0.08		0.64	-0.68	-0.17
Retained Earnings	0.08	0.83	0.55	-0.02	0.01	0.92	0.13	-0.22	0.32	0.25	-0.11	0.61	0.19	0.26	0.1	-0.35	0.05	0.76	-0.38	-0.15	-0.05	-0.05	0.64		-0.46	-0.43
Intangible Assets	0.11	-0.48	-0.12	-0.23	-0.2	-0.46	-0.43	-0.23	0.18	-0.43	-0.03	0.12	0.08	-0.48	-0.31	0.46	-0.18	-0.24	0.23	0.63	-0.41	-0.13	-0.68	-0.46		-0.33
Long Term Debt	-0.35	-0.35	-0.3	0.38	0.14	-0.41	0.45	0.28	-0.32	-0.01	0.25	-0.73	-0.3	0.24	0.33	-0.1	0.08	-0.39	0.24	-0.64	0.53	0.32	-0.17	-0.43	-0.33

Click cells to compare fundamentals

Lotus Eye Account Relationship Matchups

Lotus Eye balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	20.8M	20.8M	20.8M	20.8M	20.8M	22.2M
Total Assets	584.4M	592.3M	616.0M	631.9M	666.3M	647.5M
Short Long Term Debt Total	7.2M	4.0M	12.4M	6.7M	11.1M	5.9M
Other Current Liab	25.5M	7.6M	23.0M	20.8M	23.5M	19.8M
Total Current Liabilities	61.0M	58.2M	57.5M	51.9M	62.3M	47.1M
Total Stockholder Equity	512.6M	527.0M	546.1M	575.8M	594.1M	575.1M
Property Plant And Equipment Net	424.4M	403.7M	439.5M	440.7M	486.5M	356.9M
Net Debt	(37.5M)	(47.8M)	(25.5M)	(29.3M)	(15.4M)	(16.2M)
Cash	44.7M	51.8M	37.9M	36.0M	26.5M	24.9M
Non Current Assets Total	477.4M	456.3M	487.3M	484.8M	526.1M	539.5M
Non Currrent Assets Other	66.0M	43.1M	41.4M	29.7M	35.8M	59.4M
Cash And Short Term Investments	70.0M	98.9M	87.9M	84.1M	69.3M	46.9M
Liabilities And Stockholders Equity	584.4M	592.3M	616.0M	631.9M	666.3M	647.5M
Non Current Liabilities Total	10.9M	7.1M	12.4M	4.2M	9.9M	7.7M
Inventory	21.1M	17.8M	23.1M	27.9M	32.1M	27.5M
Other Current Assets	7.6M	11.9M	10.9M	24.2M	26.2M	15.6M
Total Liab	71.9M	65.3M	69.9M	56.1M	72.2M	52.7M
Total Current Assets	107.0M	136.0M	128.6M	147.1M	140.2M	108.0M
Current Deferred Revenue	24.0M	24.5M	17.9M	3.3M	4.2M	4.0M
Accounts Payable	24.3M	23.5M	25.2M	23.0M	34.6M	22.8M
Net Receivables	6.6M	7.4M	6.7M	11.7M	12.6M	9.7M
Short Term Debt	679K	2.6M	2.0M	1.5M	4.2M	4.4M
Retained Earnings	51.4M	67.1M	86.6M	116.9M	135.7M	69.9M
Accumulated Other Comprehensive Income	(383.9M)	469K	141K	(528K)	(977K)	(1.0M)
Intangible Assets	2.2M	1.6M	1.2M	1.0M	744K	1.2M
Long Term Debt	940K	0.0	4.0M	1.4M	1.2M	2.4M
Other Liab	6.8M	5.8M	5.8M	5.7M	6.5M	5.7M
Net Tangible Assets	499.2M	510.4M	525.3M	544.9M	626.6M	561.7M
Other Assets	49.2M	50.9M	46.6M	33.5M	38.5M	46.2M
Long Term Debt Total	4.0M	1.4M	6.7M	1.9M	2.2M	3.3M
Property Plant Equipment	424.5M	403.7M	439.5M	440.7M	506.9M	471.6M
Short Term Investments	25.3M	47.1M	50.0M	48.1M	42.8M	44.2M
Cash And Equivalents	44.7M	51.8M	37.9M	36.0M	41.4M	28.2M
Net Invested Capital	512.6M	527.0M	546.1M	575.8M	594.1M	591.9M
Net Working Capital	46.0M	77.9M	71.1M	95.2M	77.9M	60.5M
Non Current Liabilities Other	1.3M	1.8M	2.2M	2.2M	2.3M	1.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Lotus Stock Analysis

When running Lotus Eye's price analysis, check to measure Lotus Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Eye is operating at the current time. Most of Lotus Eye's value examination focuses on studying past and present price action to predict the probability of Lotus Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Eye's price. Additionally, you may evaluate how the addition of Lotus Eye to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC